Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04037514Phase 3Completed
Phase 3, randomised, double-blind trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms). Primary endpoint: Rate of closure of the hsPDA. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04037514.